ARTICLE | Company News
Merck sales and marketing update
August 22, 2016 7:00 AM UTC
Merck said it will discontinue marketing Zontivity vorapaxar in the U.S., effective Sept. 2. Merck said the decision was for “business reasons” and not related to safety and efficacy of Zontivity. As...